CJC-1295 vs BPC-157

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

CJC-1295

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce more growth hormone.

Full details →

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

Side-by-Side Comparison

AspectCJC-1295BPC-157
MechanismCJC-1295 binds to GHRH receptors in the pituitary, triggering increased production and release of growth hormone. The DAC (Drug Affinity Complex) version extends half-life significantly.BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.
Typical DosageCJC-1295 DAC: 1-2mg weekly. CJC-1295 no DAC (Mod GRF 1-29): 100-300mcg 2-3 times daily.Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.
AdministrationSubcutaneous injection, often combined with a GHRP like Ipamorelin for synergistic effects. Best administered before sleep or fasted.Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.
Side EffectsWater retention, tingling in extremities, potential increase in cortisol and prolactin levels.Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.
Best For

What They Have in Common

Both CJC-1295 and BPC-157 are commonly used for:

Key Differences

Unique to CJC-1295:

Unique to BPC-157:

Detailed Analysis

Both BPC-157 and CJC-1295 are commonly used for Muscle Growth.

Which Should You Choose?

CJC-1295 has stronger evidence for Muscle Growth.

Ready to Learn More?